SARS-CoV-2 Variants in Patients with Immunosuppression.
5 Aug, 2021 | 09:02h | UTCSARS-CoV-2 Variants in Patients with Immunosuppression – New England Journal of Medicine
Commentary on Twitter
In the pandemic, immunocompromised people (~3% of Americans) are not getting adequate recognition for the potential of in-host evolution of the virus (highlighted studies) and the need for far better approaches to protect them https://t.co/XDT1VxC9ZK @NEJM pic.twitter.com/ciw1WD9EzC
— Eric Topol (@EricTopol) August 4, 2021